Literature DB >> 20947864

Role of the dihydrofolate reductase DfrA (Rv2763c) in trimethoprim-sulfamethoxazole (co-trimoxazole) resistance in Mycobacterium tuberculosis.

Claudio U Köser, David K Summers, John A C Archer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20947864      PMCID： PMC2976105          DOI： 10.1128/AAC.00876-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  15 in total

1.  M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes.

Authors:  Asho Ali; Zahra Hasan; Tariq Moatter; Mahnaz Tanveer; Rumina Hasan
Journal:  Scand J Infect Dis       Date:  2009

2.  Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.

Authors:  Chiyoji Abe; Ikuo Kobayashi; Satoshi Mitarai; Masako Wada; Yoshiko Kawabe; Tetsuya Takashima; Katsuhiro Suzuki; Li-Hwei Sng; Suxing Wang; Hla Hla Htay; Hideo Ogata
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

3.  Reconsidering some approved antimicrobial agents for tuberculosis.

Authors:  Lowell S Young
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

4.  Tuberculosis and trimethoprim-sulfamethoxazole.

Authors:  Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.

Authors:  Michelle H Larsen; Catherine Vilchèze; Laurent Kremer; Gurdyal S Besra; Linda Parsons; Max Salfinger; Leonid Heifets; Manzour H Hazbon; David Alland; James C Sacchettini; William R Jacobs
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

6.  Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.

Authors:  W J Suling; R C Reynolds; E W Barrow; L N Wilson; J R Piper; W W Barrow
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

7.  Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia.

Authors:  Darlington M Mwenya; Bambos M Charalambous; Patrick P J Phillips; James C L Mwansa; Sarah L Batt; Andrew J Nunn; Sarah Walker; Diana M Gibb; Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

8.  Microscopic-observation drug-susceptibility assay for the diagnosis of TB.

Authors:  David A J Moore; Carlton A W Evans; Robert H Gilman; Luz Caviedes; Jorge Coronel; Aldo Vivar; Eduardo Sanchez; Yvette Piñedo; Juan Carlos Saravia; Cayo Salazar; Richard Oberhelman; Maria-Graciela Hollm-Delgado; Doris LaChira; A Roderick Escombe; Jon S Friedland
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

Review 9.  Resistance to trimethoprim-sulfamethoxazole.

Authors:  P Huovinen
Journal:  Clin Infect Dis       Date:  2001-05-04       Impact factor: 9.079

10.  Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.

Authors:  R D Fleischmann; D Alland; J A Eisen; L Carpenter; O White; J Peterson; R DeBoy; R Dodson; M Gwinn; D Haft; E Hickey; J F Kolonay; W C Nelson; L A Umayam; M Ermolaeva; S L Salzberg; A Delcher; T Utterback; J Weidman; H Khouri; J Gill; A Mikula; W Bishai; W R Jacobs; J C Venter; C M Fraser
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490
View more
  7 in total

1.  Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.

Authors:  Michaela Projahn; Claudio U Köser; Susanne Homolka; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 2.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

3.  The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

4.  The resistomes of Mycobacteroides abscessus complex and their possible acquisition from horizontal gene transfer.

Authors:  Shay Lee Chong; Joon Liang Tan; Yun Fong Ngeow
Journal:  BMC Genomics       Date:  2022-10-20       Impact factor: 4.547

5.  Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Authors:  L Davies Forsman; T Schön; U S H Simonsson; J Bruchfeld; M Larsson; P Juréen; E Sturegård; C G Giske; K Ängeby
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

6.  Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis.

Authors:  Divneet Kaur; Shalu Mathew; Chinchu G S Nair; Azitha Begum; Ashwin K Jainanarayan; Mukta Sharma; Samir K Brahmachari
Journal:  J Transl Med       Date:  2017-12-21       Impact factor: 5.531

7.  Added value of whole-genome sequencing for management of highly drug-resistant TB.

Authors:  Alexander C Outhred; Peter Jelfs; Basel Suliman; Grant A Hill-Cawthorne; Archibald B H Crawford; Ben J Marais; Vitali Sintchenko
Journal:  J Antimicrob Chemother       Date:  2014-12-09       Impact factor: 5.790
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.